Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Curtin%2C+Nicola%22&type=Person&page=4
/vufind/Search/Results?lookfor=%22Curtin%2C+Nicola%22&type=Person&page=4
Search /vufind/Search2/Results?lookfor=%22Curtin%2C+Nicola%22&type=Person&page=4
PubPharm (228)
31
Evaluating the potential of kinase inhibitors to suppress DNA repair and sensitise ovarian cancer cells to PARP inhibitors
enthalten in:
Biochemical pharmacology
| 2019
von
Mukhopadhyay, A.
|
Drew, Y.
|
Matheson, E.
| +4
Wird geladen...
32
Exploring the Frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types
enthalten in:
Cancers
| 2019
von
Gentles, L.
|
Goranov, B.
|
Matheson, E.
| +7
Wird geladen...
33
Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor
enthalten in:
Cancer medicine
| 2018
von
Franklin, M.
|
Gentles, L.
|
Matheson, E.
| +10
Wird geladen...
34
The Impact of p53 Dysfunction in ATR Inhibitor Cytotoxicity and Chemo- and Radiosensitisation
enthalten in:
Cancers
| 2018
von
Middleton, F.
|
Pollard, J.
|
Curtin, N.
Wird geladen...
35
Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase
enthalten in:
Blood advances
| 2018
von
Fordham, S.
|
Blair, H.
|
Elstob, C.
| +15
Wird geladen...
36
Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer
enthalten in:
Oncotarget
| 2018
von
Unterlass, J.
|
Baslé, A.
|
Blackburn, T.
| +4
Wird geladen...
37
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases
enthalten in:
British journal of pharmacology
| 2018
von
Berger, N.
|
Besson, V.
|
Boulares, A.
| +19
Wird geladen...
38
Targeting the DNA damage response for anti-cancer therapy
Erschienen: Cham, Switzerland,
Humana Press,
[2018]
Cancer drug discovery and development
von
Pollard, J.
|
Curtin, N.
Wird geladen...
39
Targeting the DNA Damage Response for Anti-Cancer Therapy
Erschienen: Cham,
Springer International Publishing,
2018
Cancer Drug Discovery and Development
von
Pollard, J.
|
Curtin, N.
Wird geladen...
40
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases
Erschienen: Konstanz,
KOPS Universität Konstanz,
2018
von
Berger, N.
|
Besson, V.
|
Boulares, A.
| +7
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
218
Aufsätze
127
E-Ressourcen
121
E-Artikel
97
Gedruckte Aufsätze
10
Bücher
6
E-Books
4
Gedruckte Bücher
1
Hochschulschriften
Alle anzeigen ...
weniger ...
Zeitschriftentitel
17
Journal of medicinal chemistry
14
Clinical cancer research
13
Molecular cancer therapeutics
12
Cancer chemotherapy and pharmacology
12
Cancers
10
Clinical cancer research : an official journal ...
9
Bioorganic & medicinal chemistry letters
9
Cancer research
8
Breast cancer research and treatment
7
Oncotarget
4
Expert reviews in molecular medicine
4
Journal of the National Cancer Institute
4
Methods in molecular biology (Clifton, N.J.)
4
Molecular oncology
4
Organic & biomolecular chemistry
3
Biochemical Society transactions
3
International journal of gynecological cancer
3
Journal of hepatology
3
PloS one
3
bioRxiv.org
Alle anzeigen ...
weniger ...
Thema
129
Journal Article
75
Research Support, Non-U.S. Gov't
47
Poly(ADP-ribose) Polymerase Inhibitors
41
Antineoplastic Agents
31
EC 2.7.11.1
29
Enzyme Inhibitors
27
EC 2.4.2.30
24
Poly(ADP-ribose) Polymerases
22
Indoles
20
Review
19
rucaparib
17
8237F3U7EH
17
DNA-Activated Protein Kinase
16
Protein Kinase Inhibitors
15
7GR28W0FJI
15
Dacarbazine
15
Temozolomide
15
YF1K15M17Y
14
Ataxia Telangiectasia Mutated Proteins
13
ATR
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
20
2020-
121
2010-2019
72
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
174
Englisch
Haven't found what you're looking for?
Wird geladen...